<h1>Dr. Patrick Finley provides evidence of a clinically significant CYP2D6 drug interaction  when combining antidepressants with beta-blockers.</h1>
<p>Full manuscript available at: <a href="https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2406">https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2406</a></p>

Dr. Patrick Finley provides evidence of a clinically significant CYP2D6 drug interaction when combining antidepressants with beta-blockers. Full manuscript available at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2406

Dr. Patrick Finley provides evidence of a clinically significant CYP2D6 drug interaction &nbsp;when combining antidepressants with beta-blockers.
<p>Full manuscript available at: <a href="https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2406" rel="noopener noreferrer">https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2406</a></p>

Combining Antidepressants with β‐Blockers - Episode 32

This podcast brings you interviews with journal authors providing insight on their recent publication in an official journal of the American College of Clinical Pharmacy. Pharmacotherapy publishes advances in human pharmacology and drug therapy and the JACCP publishes innovations in clinical pharmacy practice.
ACCP JOURNALS DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.

Medicine

Health & Fitness

This podcast brings you interviews with journal authors providing insight on their recent publication in an official journal of the American College of Clinical Pharmacy. Pharmacotherapy publishes advances in human pharmacology and drug therapy and the JACCP publishes innovations in clinical pharmacy practice. ACCP JOURNALS DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.

Share Combining Antidepressants with β‐Blockers - Episode 32

Sign up to save your podcasts

Combining Antidepressants with β‐Blockers - Episode 32

Combining Antidepressants with β‐Blockers - Episode 32

More shows like ACCP JOURNALS

EMCrit FOAM Feed

Gastropod

The Daily

Today, Explained